Question 1

How does ellipticine from Ochrosia work as an anticancer compound?

Accepted Answer

Ellipticine, the primary active alkaloid in Ochrosia elliptica, works through multiple anticancer mechanisms. It functions as a DNA intercalator, inserting itself between DNA base pairs to disrupt replication. Additionally, ellipticine inhibits topoisomerase II, an enzyme critical for DNA replication and cell division. These mechanisms cause DNA damage and trigger cancer cell death. Research also suggests ellipticine generates reactive oxygen species that contribute to its cytotoxic effects (Evidence Level C - preclinical research).

Question 2

Does Ochrosia elliptica interact with chemotherapy medications?

Accepted Answer

Ochrosia elliptica and its ellipticine alkaloids may significantly interact with chemotherapy drugs. Because ellipticine inhibits topoisomerase II and intercalates DNA, combining it with other topoisomerase inhibitors such as doxorubicin or etoposide could increase toxicity risks, including bone marrow suppression and cardiac effects. The herb's potential liver toxicity may compound hepatotoxic chemotherapy side effects. Patients undergoing cancer treatment should avoid self-medicating with Ochrosia preparations without oncologist supervision (Evidence Level C).

Question 3

What is the recommended dosage for Ochrosia elliptica?

Accepted Answer

There is no established safe dosage for Ochrosia elliptica for self-medication. The plant contains potent alkaloids, particularly ellipticine, which require pharmaceutical isolation and medical supervision for therapeutic use. Traditional Pacific Islander applications involved specific preparations for fever and skin conditions, but these methods have not been standardized or clinically validated. Due to mutagenic properties and potential liver toxicity, Ochrosia should only be used under medical supervision in approved pharmaceutical contexts (Evidence Level C).

Question 4

Is Ochrosia elliptica safe to use during pregnancy?

Accepted Answer

No, Ochrosia elliptica is contraindicated during pregnancy. The plant contains ellipticine and related alkaloids that have demonstrated mutagenic and potentially teratogenic properties. These compounds can interfere with DNA replication and cell division, posing significant risks to fetal development. Traditional use did not include pregnant women. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid all Ochrosia preparations. The potential for birth defects and developmental harm outweighs any possible benefits (Evidence Level C).

Question 5

What are the traditional uses of Ochrosia elliptica?

Accepted Answer

Ochrosia elliptica has been used traditionally in Pacific Island medicine primarily for treating fevers and various skin conditions. Australian Aboriginal communities historically employed preparations from this plant for managing infections. The tree, native to Pacific islands and parts of Australia, was valued for its antimicrobial and anti-inflammatory properties in folk medicine. However, these traditional applications have limited clinical documentation, and modern pharmaceutical research focuses on isolating ellipticine for anticancer drug development rather than validating traditional preparations (Evidence Level C, Traditional).

Ochrosia elliptica

Sources & Citations

Kunzea Ambigua

Bridelia Ferruginea

Fomes Fomentarius

Summary

Background

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources